157 related articles for article (PubMed ID: 35843311)
1. Phosphorylation of mixed lineage kinase MLK3 by cyclin-dependent kinases CDK1 and CDK2 controls ovarian cancer cell division.
Cedeno-Rosario L; Honda D; Sunderland AM; Lewandowski MD; Taylor WR; Chadee DN
J Biol Chem; 2022 Aug; 298(8):102263. PubMed ID: 35843311
[TBL] [Abstract][Full Text] [Related]
2. SP600125 suppresses Cdk1 and induces endoreplication directly from G2 phase, independent of JNK inhibition.
Kim JA; Lee J; Margolis RL; Fotedar R
Oncogene; 2010 Mar; 29(11):1702-16. PubMed ID: 20062077
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of mixed-lineage kinase (MLK) activity during G2-phase disrupts microtubule formation and mitotic progression in HeLa cells.
Cha H; Dangi S; Machamer CE; Shapiro P
Cell Signal; 2006 Jan; 18(1):93-104. PubMed ID: 15923109
[TBL] [Abstract][Full Text] [Related]
4. Delta MEKK3:ER* activation induces a p38 alpha/beta 2-dependent cell cycle arrest at the G2 checkpoint.
Garner AP; Weston CR; Todd DE; Balmanno K; Cook SJ
Oncogene; 2002 Nov; 21(53):8089-104. PubMed ID: 12444545
[TBL] [Abstract][Full Text] [Related]
5. Phosphorylation of CDC25C by AMP-activated protein kinase mediates a metabolic checkpoint during cell-cycle G
Shen Y; Sherman JW; Chen X; Wang R
J Biol Chem; 2018 Apr; 293(14):5185-5199. PubMed ID: 29467227
[TBL] [Abstract][Full Text] [Related]
6. Requirements for Cdk7 in the assembly of Cdk1/cyclin B and activation of Cdk2 revealed by chemical genetics in human cells.
Larochelle S; Merrick KA; Terret ME; Wohlbold L; Barboza NM; Zhang C; Shokat KM; Jallepalli PV; Fisher RP
Mol Cell; 2007 Mar; 25(6):839-50. PubMed ID: 17386261
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of cell proliferation and cell cycle progression by specific inhibition of basal JNK activity: evidence that mitotic Bcl-2 phosphorylation is JNK-independent.
Du L; Lyle CS; Obey TB; Gaarde WA; Muir JA; Bennett BL; Chambers TC
J Biol Chem; 2004 Mar; 279(12):11957-66. PubMed ID: 14704147
[TBL] [Abstract][Full Text] [Related]
8. Cyclin A-associated kinase activity is needed for paclitaxel sensitivity.
Takahashi T; Yamasaki F; Sudo T; Itamochi H; Adachi S; Tamamori-Adachi M; Ueno NT
Mol Cancer Ther; 2005 Jul; 4(7):1039-46. PubMed ID: 16020661
[TBL] [Abstract][Full Text] [Related]
9. Quantitative differences between cyclin-dependent kinases underlie the unique functions of CDK1 in human cells.
Lau HW; Ma HT; Yeung TK; Tam MY; Zheng D; Chu SK; Poon RYC
Cell Rep; 2021 Oct; 37(2):109808. PubMed ID: 34644583
[TBL] [Abstract][Full Text] [Related]
10. S and G2 phase roles for Cdk2 revealed by inducible expression of a dominant-negative mutant in human cells.
Hu B; Mitra J; van den Heuvel S; Enders GH
Mol Cell Biol; 2001 Apr; 21(8):2755-66. PubMed ID: 11283255
[TBL] [Abstract][Full Text] [Related]
11. Longikaurin A, a natural ent-kaurane, induces G2/M phase arrest via downregulation of Skp2 and apoptosis induction through ROS/JNK/c-Jun pathway in hepatocellular carcinoma cells.
Liao YJ; Bai HY; Li ZH; Zou J; Chen JW; Zheng F; Zhang JX; Mai SJ; Zeng MS; Sun HD; Pu JX; Xie D
Cell Death Dis; 2014 Mar; 5(3):e1137. PubMed ID: 24651440
[TBL] [Abstract][Full Text] [Related]
12. The Cyclin-dependent kinase inhibitor CYC202 (R-roscovitine) inhibits retinoblastoma protein phosphorylation, causes loss of Cyclin D1, and activates the mitogen-activated protein kinase pathway.
Whittaker SR; Walton MI; Garrett MD; Workman P
Cancer Res; 2004 Jan; 64(1):262-72. PubMed ID: 14729633
[TBL] [Abstract][Full Text] [Related]
13. Dual regulation of the anaphase promoting complex in human cells by cyclin A-Cdk2 and cyclin A-Cdk1 complexes.
Mitra J; Enders GH; Azizkhan-Clifford J; Lengel KL
Cell Cycle; 2006 Mar; 5(6):661-6. PubMed ID: 16582612
[TBL] [Abstract][Full Text] [Related]
14. Hsp90/p50cdc37 is required for mixed-lineage kinase (MLK) 3 signaling.
Zhang H; Wu W; Du Y; Santos SJ; Conrad SE; Watson JT; Grammatikakis N; Gallo KA
J Biol Chem; 2004 May; 279(19):19457-63. PubMed ID: 15001580
[TBL] [Abstract][Full Text] [Related]
15. Critical reanalysis of the methods that discriminate the activity of CDK2 from CDK1.
Sakurikar N; Eastman A
Cell Cycle; 2016 May; 15(9):1184-8. PubMed ID: 26986210
[TBL] [Abstract][Full Text] [Related]
16. Roles of human epidermal growth factor receptor 2, c-jun NH2-terminal kinase, phosphoinositide 3-kinase, and p70 S6 kinase pathways in regulation of cyclin G2 expression in human breast cancer cells.
Le XF; Arachchige-Don AS; Mao W; Horne MC; Bast RC
Mol Cancer Ther; 2007 Nov; 6(11):2843-57. PubMed ID: 18025271
[TBL] [Abstract][Full Text] [Related]
17. v-Jun overrides the mitogen dependence of S-phase entry by deregulating retinoblastoma protein phosphorylation and E2F-pocket protein interactions as a consequence of enhanced cyclin E-cdk2 catalytic activity.
Clark W; Black EJ; MacLaren A; Kruse U; LaThangue N; Vogt PK; Gillespie DA
Mol Cell Biol; 2000 Apr; 20(7):2529-42. PubMed ID: 10713176
[TBL] [Abstract][Full Text] [Related]
18. Pre-clinical evaluation of cyclin-dependent kinase 2 and 1 inhibition in anti-estrogen-sensitive and resistant breast cancer cells.
Johnson N; Bentley J; Wang LZ; Newell DR; Robson CN; Shapiro GI; Curtin NJ
Br J Cancer; 2010 Jan; 102(2):342-50. PubMed ID: 20010939
[TBL] [Abstract][Full Text] [Related]
19. [The characterization of human cdc2 kinase and CDK2].
Yasuda H; Kamijo M; Ohba Y
Yakugaku Zasshi; 1993 Dec; 113(12):829-46. PubMed ID: 8301538
[TBL] [Abstract][Full Text] [Related]
20. Effect of the WWOX gene on the regulation of the cell cycle and apoptosis in human ovarian cancer stem cells.
Yan H; Tong J; Lin X; Han Q; Huang H
Mol Med Rep; 2015 Aug; 12(2):1783-8. PubMed ID: 25891642
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]